ARISING HEALTHALIVE. AWAKE. AWARE.Read the magazines →
← All Living Magazines

THE ARISING / EVERYDAY HEALTH

Addiction & Recovery

The next step should be easier to take

A Living Magazine · updated as evidence is reviewed

Imagine leaving an emergency department after surviving an overdose. What happens next may be a phone number on a piece of paper, or it may be a conversation about starting treatment while someone is still there to help. The person walking out is the same. Their chances of making it to care can be different.

Name what is happening

A substance use disorder involves a pattern that causes harm or distress, such as difficulty controlling use, continuing despite consequences, or losing the ability to meet obligations. A person can develop physical dependence on a prescribed medicine and experience withdrawal when it is stopped without having a substance use disorder. The conditions can overlap, but a diagnosis takes more than noticing tolerance or withdrawal. Specific words also help: alcohol use disorder, opioid use disorder, and stimulant use disorder have different risks and treatment options. Gambling disorder and gaming disorder have separate definitions in the World Health Organization's classification. Being on a phone or playing a game for many hours does not, by itself, establish a disorder. SAMHSA clinical guidance · WHO on addictive behaviours

That precision should extend to the person. “A person with opioid use disorder” leaves space for the rest of their life. In a visit, “What has the substance been doing for you, and what has it been costing you?” may take the conversation further than a label. People should not have to prove they are ready for a perfect recovery before they can ask what help is available. NIH on language and stigma

What treatment changes

For opioid use disorder, the FDA has approved buprenorphine, methadone, and naltrexone. The choice is individual. The treatments have different requirements for how they begin, how patients receive them, and what makes them suitable. In a Massachusetts cohort of adults who survived an opioid overdose, methadone and buprenorphine use was associated with lower subsequent mortality. This was an observational comparison, so it cannot predict exactly what will happen to any one person or settle the best option for everyone. SAMHSA medication guide · Massachusetts post-overdose cohort

The way treatment is offered matters too. In a single emergency department's randomized trial, 89 of 114 people offered buprenorphine and a follow-up appointment were engaged in treatment at 30 days, compared with 38 of 102 people evaluated after a referral. The trial tested a connection to care as well as a medicine. It did not show that one visit guarantees long-term recovery. Emergency department initiation trial

For alcohol use disorder, medications are also an option. The large COMBINE trial found a benefit for naltrexone with medical management in a selected group of recently abstinent adults. Acamprosate is another approved option clinicians may discuss; choices depend on goals, other medicines, and medical history. A 26-week trial in 108 treatment-seeking adults with both alcohol use disorder and obesity found fewer heavy drinking days with semaglutide than with placebo, alongside behavioral therapy in both groups. Stomach and gut side effects were more frequent with semaglutide. The result does not tell us how it works in people without obesity, or for other substance use disorders. For stimulant use disorder, current clinical guidance makes contingency management, which reinforces agreed treatment goals, a primary part of care alongside other psychosocial support. COMBINE randomized trial · NIAAA treatment options · Semaglutide trial · ASAM and AAAP stimulant guideline

A separate early-phase tirzepatide study is testing how people with alcohol use disorder and healthy volunteers respond to cues and measuring dopamine-related signals. Its registration describes research in progress, not a successful treatment. That distinction is worth keeping as the headlines get ahead of the evidence. ClinicalTrials.gov registry

Make safety part of the plan

If someone is unresponsive or is breathing slowly or not at all and you suspect an opioid overdose, give naloxone if it is available and call 911 in the United States. Stay until help arrives and follow the dispatcher's directions. Naloxone reverses opioid overdose temporarily; someone who wakes up still needs emergency help. Having naloxone nearby can buy time while the larger work of recovery continues. CDC overdose response

Heavy, regular drinking raises a different safety issue. For someone who may be physically dependent on alcohol, suddenly stopping can trigger dangerous withdrawal, including seizures. A clinician can help plan a safe start. A seizure, severe confusion, or hallucinations after reducing alcohol needs emergency attention. Getting through withdrawal is one part of care; follow-up matters as much as finding a safe way to begin. ASAM alcohol withdrawal guideline

Where to start

Make the next step specific enough to act on: a clinician to call, an appointment already arranged, a person who can come with you, a pharmacy or community program that can provide naloxone. Pregnancy, opioid exposure, mental health symptoms, and other medicines may change what care is safest. It is useful to tell the care team about those details, not a reason to sit at home and sort them out alone.

In the U.S., FindTreatment.gov and SAMHSA's 1-800-662-HELP (4357) line can help people and families locate care. These are referral resources, not emergency lines.

Connected reading: Care & independence · Stress & mental health · GLP-1 & metabolic health

General education, not individual medical advice.

THE ARISING NEWSLETTER

Science moves forward.
Come with it.

Research, clear explanations, and a little room for wonder.
Read and follow The Arising on Substack.

Find The Arising on Substack ↗